Literature DB >> 12771407

Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus.

Finn Grey1, Mike Sowa2, Peter Collins2, Rob J Fenton2, Wendy Harris2, Wendy Snowden2, Stacey Efstathiou1, Graham Darby2.   

Abstract

A clinical isolate of herpes simplex virus type 1 that is aciclovir resistant but neurovirulent in mice was described previously. The mutation in this virus is a double G insertion in a run of seven G residues that has been shown previously to be a mutational hotspot. Using a sensitive assay, it has been demonstrated that preparations of this virus are able to induce low but consistent levels of thymidine kinase (TK) activity. However, this activity results from a high frequency mutational event that inserts a further G into the 'G-string' motif and thus restores the TK open reading frame. Passage of this virus through the nervous system of mice results in the rapid selection of the TK-positive variant. Thus, this variant is the major component in virus reactivated from latently infected ganglia. Mutation frequency appears to be influenced by the genetic background of the virus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771407     DOI: 10.1099/vir.0.18881-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.

Authors:  Dongli Pan; Donald M Coen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.

Authors:  Anthony Griffiths
Journal:  Drug Resist Updat       Date:  2011-09-22       Impact factor: 18.500

3.  Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.

Authors:  Anthony Griffiths; Malen A Link; Caroline L Furness; Donald M Coen
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  The herpes simplex virus 2 virion-associated ribonuclease vhs interferes with stress granule formation.

Authors:  Renée L Finnen; Thomas J M Hay; Bianca Dauber; James R Smiley; Bruce W Banfield
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

5.  Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.

Authors:  Kening Wang; Gowtham Mahalingam; Susan E Hoover; Erik K Mont; Steven M Holland; Jeffrey I Cohen; Stephen E Straus
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 6.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

7.  A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.

Authors:  Moriah L Szpara; Yolanda R Tafuri; Lance Parsons; S Rafi Shamim; Kevin J Verstrepen; Matthieu Legendre; L W Enquist
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

8.  Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.

Authors:  Natsumi Omura; Hikaru Fujii; Tomoki Yoshikawa; Souichi Yamada; Shizuko Harada; Takuya Inagaki; Miho Shibamura; Haruko Takeyama; Masayuki Saijo
Journal:  Virol J       Date:  2017-03-21       Impact factor: 4.099

Review 9.  Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency.

Authors:  Nikki M Thellman; Steven J Triezenberg
Journal:  Pathogens       Date:  2017-06-23

10.  Evolution and diversity in human herpes simplex virus genomes.

Authors:  Moriah L Szpara; Derek Gatherer; Alejandro Ochoa; Benjamin Greenbaum; Aidan Dolan; Rory J Bowden; Lynn W Enquist; Matthieu Legendre; Andrew J Davison
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.